Epidarex

Epidarex Capital – Catalyzing innovation in health science and technology

Epidarex Capital Creates Nodthera Limited

A pioneering new company based on Selvita research and utilizing novel immunological approaches to disease Edinburgh, Scotland, July 28, 2016:  Epidarex Capital today announces the launch of Nodthera Limited, a new biotech company focused on the discovery and development of novel inhibitors of the NLRP3…

Mironid Announces Closing of £4.3 million Series A Financing

Glasgow, Scotland, UK, 20th June 2016: Mironid Ltd, a leader in cell signalling directed drug development, today announced the closing of its Series A funding round of £4.3 million ($6.2 million), which will support the Company’s internal research and preclinical development programmes, focused on degenerative…

Glasgow Diabetes Spin-Out Caldan Beefs Up Boardroom

By Gareth Mackie, The Scotsman A university spin-out that specialises in potential treatments for type 2 diabetes has bolstered its boardroom in the wake of a £4.5 million cash injection. Glasgow-based Caldan Therapeutics, a spin-out from the universities of Glasgow and Southern Denmark, has appointed…